👀 Copy Legendary Investors' Portfolios in One ClickCopy For Free

HSBC downgrades Morgan Stanley stock to Hold, sees 3% downside after 29% rise

EditorAhmed Abdulazez Abdulkadir
Published 26/11/2024, 10:28
MS
-

On Tuesday, HSBC adjusted its stance on Morgan Stanley (NYSE:MS), shifting the rating from Buy to Hold. The financial firm also increased its price target for the investment bank's shares to $131.00, up from the previous target of $128.00. This revision comes after a notable 29% increase in Morgan Stanley's share price since September 2024.

The analyst at HSBC noted a recent change in sentiment towards Morgan Stanley's stock, which was spurred by a break in a multi-year downward trend in earnings revisions. Additionally, the firm's Wealth Management division has seen strong fee-based net flows that were previously underappreciated. Morgan Stanley's potential benefit from an investment banking (IB) recovery cycle was also highlighted as a positive factor.

Despite these favorable developments, HSBC believes that Morgan Stanley's current market valuation now reflects a balanced risk-reward scenario. The analyst pointed out that for Goldman Sachs (GS), as with Morgan Stanley, expectations have increased. Moving forward, the ability to consistently deliver good net new asset flows and robust IB fee growth will be crucial, especially when compared to tougher comparables from previous years.

The revised price target suggests a slight downside of approximately 3%, aligning with the Hold rating. HSBC's updated view reflects a cautious outlook on Morgan Stanley's future performance, acknowledging the challenges of maintaining strong growth against a backdrop of heightened expectations.

InvestingPro Insights

Recent data from InvestingPro adds context to HSBC's revised outlook on Morgan Stanley. The company's P/E ratio stands at 20.11, which aligns with an InvestingPro Tip noting that MS is "Trading at a high P/E ratio relative to near-term earnings growth." This valuation metric supports HSBC's view that the current market price may already reflect much of the company's potential upside.

Despite the cautious stance, Morgan Stanley's financial health appears robust. The company boasts a revenue of $58.28 billion over the last twelve months as of Q3 2024, with a strong revenue growth of 9.18% during the same period. This solid performance is underscored by another InvestingPro Tip highlighting that MS is a "Prominent player in the Capital Markets industry."

For investors seeking additional insights, InvestingPro offers 14 more tips on Morgan Stanley, providing a comprehensive view of the company's financial position and market performance. These tips could be particularly valuable in understanding the nuances behind HSBC's rating change and the potential future trajectory of Morgan Stanley's stock.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2024 - Fusion Media Limited. All Rights Reserved.